About Us

One Planet. One Health.

We are a subsidiary of Double Bond Pharmaceutical (https://www.doublebp.com/). Our company is active in the development and distribution of veterinary products, and our first product is for the prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics.

Why us?

The rise of antibiotic-resistant bacteria in the world has reached devastating levels taking more than 700 000 human lives annually worldwide, and will kill over 10 million by 2050, which is more than cancer and equals to one person in every three seconds. Numerous studies have demonstrated that the routine use of antibiotics on farms promotes drug-resistant superbugs. This is because there are always some bacteria that the drug can’t kill, and they survive and proliferate.

The US Food and Drug Administration (FDA) claims that 80% of all antibiotics sold in the US are fed to food animals, with 70% of them being essential to human medicine. In China this number is higher. Globally, consumption of antimicrobials by livestock is set to continue increasing and is estimated by Princeton Environmental Institute to rise by two-thirds between now and 2030.

The UK government’s Review on Antimicrobial Resistance and a report on antimicrobial resistance from the European Centre for Disease Prevention and Control (ECDC) from November 15, 2017 contend that the rising number of infections resistant to antibiotics has set the world on the brink of catastrophe. Recently, in a literature review, only 5% of the 139 academic papers identified, argued there was no link between the antibiotic consumption in animals and the resistance in humans, while 72% found the evidence of the link. Since the livestock industry has put the society in a fundamental health danger of this magnitude, it can and should also help to stop it. This is why our company and our product exist today.

This resulted in several actions undertaken by different authorities to reduce the use of antibiotics in animals. In particular, it is prohibited to use antibiotics as growth promotors in EU from 2006 and in USA from 2017, moreover, EU bans the prophylactic and metaphylactic use of antibiotics in farming from 2022. These actions increasingly restricting farmers in the fight against infection, forcing them to change their way of working in the absence of alternatives, creating a great unmet need for universal alternatives to antibiotics to break the infection cascade in cattle.

FarmPharma provides farmers an essential new therapy, InterferOx, with broad applicability for many infections, significantly improving treatment options, while complying with official regulations. It can replace antibiotics and thereby stimulate their prudent use in animals, especially ones of medical importance to human health.